Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Rapid reversal of anticoagulation prevents excessive secondary hemorrhage after thrombolysis in a thromboembolic model in rats.

Sun L, Zhou W, Ploen R, Heiland S, Zorn M, Veltkamp R.

Stroke. 2011 Dec;42(12):3524-9. doi: 10.1161/STROKEAHA.110.608059. Epub 2011 Sep 29.

2.

Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.

Ploen R, Sun L, Zhou W, Heitmeier S, Zorn M, Jenetzky E, Veltkamp R.

J Cereb Blood Flow Metab. 2014 Mar;34(3):495-501. doi: 10.1038/jcbfm.2013.226. Epub 2013 Dec 18.

3.

Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.

Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K.

Stroke. 2014 Aug;45(8):2404-10. doi: 10.1161/STROKEAHA.114.005316. Epub 2014 Jul 1.

4.

Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.

Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.

Ann Neurol. 2012 May;71(5):624-33. doi: 10.1002/ana.23558. Epub 2012 Mar 23.

PMID:
22447744
5.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

6.

Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.

Busch E, Krüger K, Allegrini PR, Kerskens CM, Gyngell ML, Hoehn-Berlage M, Hossmann KA.

J Cereb Blood Flow Metab. 1998 Apr;18(4):407-18.

7.

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

Yasaka M, Sakata T, Naritomi H, Minematsu K.

Thromb Res. 2005;115(6):455-9.

PMID:
15792675
8.

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC.

Pfeilschifter W, Spitzer D, Pfeilschifter J, Steinmetz H, Foerch C.

PLoS One. 2011;6(10):e26087. doi: 10.1371/journal.pone.0026087. Epub 2011 Oct 19.

9.

Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.

Chapman SA, Irwin ED, Beal AL, Kulinski NM, Hutson KE, Thorson MA.

Ann Pharmacother. 2011 Jul;45(7-8):869-75. doi: 10.1345/aph.1P605. Epub 2011 Jul 20.

PMID:
21775690
10.

A translationally relevant thromboembolic stroke model for the study of secondary hemorrhage after thrombolysis in rats.

Sun L, Zhou W, Heiland S, Marti HH, Veltkamp R.

Brain Res. 2011 Jan 12;1368:346-54. doi: 10.1016/j.brainres.2010.10.067. Epub 2010 Oct 23.

PMID:
20974110
11.

Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.

Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti HH, Veltkamp R.

J Cereb Blood Flow Metab. 2010 Sep;30(9):1651-60. doi: 10.1038/jcbfm.2010.50. Epub 2010 Apr 28.

12.

[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Angelo M, Stockner I, Wiedermann CJ.

Wien Med Wochenschr. 2008;158(21-22):615-20. doi: 10.1007/s10354-008-0610-3. Review. German.

PMID:
19052707
13.

Cerebral venous congestion as indication for thrombolytic treatment.

Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH.

Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87.

PMID:
17573553
14.

Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.

Seet RC, Zhang Y, Moore SA, Wijdicks EF, Rabinstein AA.

Stroke. 2011 Aug;42(8):2333-5. doi: 10.1161/STROKEAHA.111.614214. Epub 2011 Jun 9.

15.

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.

Majeed A, Eelde A, Agren A, Schulman S, Holmström M.

Thromb Res. 2012 Feb;129(2):146-51. doi: 10.1016/j.thromres.2011.07.024. Epub 2011 Jul 31.

PMID:
21807399
16.

The use of vitamin K in patients on anticoagulant therapy: a practical guide.

Hanslik T, Prinseau J.

Am J Cardiovasc Drugs. 2004;4(1):43-55. Review.

PMID:
14967065
17.

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.

Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W.

Stroke. 2000 Jun;31(6):1318-28.

18.
19.
20.

Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model.

Saguchi T, Onoue H, Urashima M, Ishibashi T, Abe T, Furuhata H.

Stroke. 2008 Mar;39(3):1007-11. doi: 10.1161/STROKEAHA.107.496117. Epub 2008 Jan 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk